Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ngs_agd
    Junior Member
    • Feb 2011
    • 7

    #1

    duplicate reads in enriched samples

    Hi all,
    I have some RNAseq data (enriched and non-enriched) generated on Illumina. I am seeing a lot of duplicate reads (as well as much higher read depth) in the enriched dataset. Does enrichment result in excess duplicate reads? If yes, what is the best way to deal with them.

    Thanks in advance for your help.



    P.S. I have been reading SEQanswers for a while now. It is an excellent source of information.
  • Seq84
    Member
    • Feb 2011
    • 19

    #2
    Originally posted by ngs_agd View Post
    Hi all,
    I have some RNAseq data (enriched and non-enriched) generated on Illumina. I am seeing a lot of duplicate reads (as well as much higher read depth) in the enriched dataset. Does enrichment result in excess duplicate reads? If yes, what is the best way to deal with them.

    Thanks in advance for your help.



    P.S. I have been reading SEQanswers for a while now. It is an excellent source of information.
    I'm interesting in this issue too, in our target resequencing experiment we detected a wide range of % in duplicates (from 2 to 80 %). Is it normal that in a target reseq experiment % of duplicates raise?

    Comment

    • Heisman
      Senior Member
      • Dec 2010
      • 534

      #3
      I said in another thread that I communicated by email with an Agilent rep and the main determining factor to duplicates is the number of PCR cycles pre-hybridization. With 7 or 8 cycles I see < 5% duplicates.

      Comment

      • Seq84
        Member
        • Feb 2011
        • 19

        #4
        Thanks for your reply Heisman, next time will decrease number of cycles!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        43 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Working...